JPRN-UMIN000010477
Completed
N/A
Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in acute cardioembolic stroke with nonvalvular atrial fibrillation. - Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in acute cardioembolic stroke with nonvalvular atrial fibrillation.
Department of Neurology, Kansai Medical University0 sites50 target enrollmentApril 22, 2013
Conditionscerebral infarction
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- cerebral infarction
- Sponsor
- Department of Neurology, Kansai Medical University
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)extensive cerebral infarction(more than one third of the middle cerebral artery territory) 2\)severe dysphagia 3\)hepatic function disorder (Child\-Pugh B or C) 4\)renal dysfunction (CCr\<30ml/min) 5\)anemia (Hb\<10\.0g/dl) 6\)hemorrhagic event
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery.arterial fibrillation after cardiac surgery (nonvalvular disease)JPRN-UMIN000021138ihon University school of medicine150
Not Yet Recruiting
N/A
The efficacy and safety of anticoagulant therapy Arixtra Injection for the prevention of the vein thromboembolism in laparoscopic colorectal surgerycolorectal cancerJPRN-UMIN000007005Osaka Medical College200
Completed
N/A
A Study of Safety and efficacy of anticoagulant therapy in the treatment of Atrial Fibrillation in KANAGAWAAtrial fibrillationJPRN-UMIN000011830ASSAF-K steering committee5,000
Not Yet Recruiting
Phase 3
Effectiveness and safety of blood thinning agent (Anticoagulation) in patients with dying limb with poor blood supply (Digital Gangrene) and an underlying immune system related disease (Connective Tissue Disease)Health Condition 1: M339- Dermatopolymyositis, unspecifiedHealth Condition 2: M319- Necrotizing vasculopathy, unspecifiedHealth Condition 3: M340- Progressive systemic sclerosisHealth Condition 4: M368- Systemic disorders of connective tissue in other diseases classified elsewhereHealth Condition 5: M359- Systemic involvement of connectivetissue, unspecifiedHealth Condition 6: M321- Systemic lupus erythematosus withorgan or system involvementCTRI/2024/03/063481Department of Clinical Immunology & Rheumatology
Completed
N/A
The efficacy of pro- and anticoagulant therapy in plasma from patients with liver cirrhosis .coagulation.hemostasis10064477NL-OMON37417niversitair Medisch Centrum Groningen126